This contract expires in 311 days (Jul 20, 2027).
OLINK PROTEOMICS INC - MYELODYSPLASTIC SYNDROMES ARE HETEROGENEOUS STEM CELL MALIGNANCIES CHARACTERIZED BY CHRONIC INFLAMMATION, PERIPHERAL CYTOPENIAS, AND BONE MARROW DYSPLASIA. LRBGE PRELIMINARY DATA FROM TARGETED PROTEOMIC ARRAYS HAS IDENTIFIED SUBSTANTIAL CHANGES IN TH
Key Details
Description
MYELODYSPLASTIC SYNDROMES ARE HETEROGENEOUS STEM CELL MALIGNANCIES CHARACTERIZED BY CHRONIC INFLAMMATION, PERIPHERAL CYTOPENIAS, AND BONE MARROW DYSPLASIA. LRBGE PRELIMINARY DATA FROM TARGETED PROTEOMIC ARRAYS HAS IDENTIFIED SUBSTANTIAL CHANGES IN TH
Context & Analysis
On Jul 22, 2026, Department of Health and Human Services obligated $47,300 to OLINK PROTEOMICS INC for myelodysplastic syndromes are heterogeneous stem cell malignancies characterized by chronic inflammation, peripheral cytopenias, and bone marrow dysplasia. lrbge preliminary data from targeted proteom…. The award is classified under NAICS 541380 — TESTING LABORATORIES AND SERVICES. Competition extent: not competed under sap with 1 offer received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BETHESDA, MD. The contract is scheduled through Jul 20, 2027 — approximately 10 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541380 — related awards are listed below.
Contractor Information
Similar Awards
WASTEWATER SURVEILLANCE TESTING
VERILY HEALTH INC.
$42.3M
INNOVATION FUNNEL FOR COVID-19 - VALIDATION CENTER
EMORY UNIVERSITY
$41.2M
STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.
LOVELACE BIOMEDICAL RESEARCH INSTITUTE
$38.8M
CENTRALIZED OMICS RESOURCE (CORE) YEAR 5
THE BROAD INSTITUTE, INC
$36.4M
NHLBI TRANS-OMICS FOR PRECISION MEDICINE (TOPMED) FOR THE CENTRALIZED OMICS RESOURCE (CORE) - TASK AREAS 2, 3, AND 4 - 2024 TASK ORDER
THE BROAD INSTITUTE, INC
$24.5M
Stay Updated
Get notified about new opportunities matching your interests.